A British Society for Haematology good practice paper: Recommendations for laboratory testing of UK patients with acute myeloid leukaemia

被引：4
|
作者：
Mehta, Priyanka [1 ]
Telford, Nick [2 ]
Wragg, Chris [3 ]
Dillon, Richard [4 ]
Freeman, Sylvie [5 ]
Finnegan, Damian [6 ]
Hamblin, Angela [7 ]
Copland, Mhairi [8 ]
Knapper, Steve [9 ]
机构：
[1] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, Avon, England
[2] Christie NHS Fdn Trust, Oncol Cytogenet, Manchester, Lancs, England
[3] North Bristol NHS Trust, Bristol Genet Lab, Westbury On Trym, England
[4] Kings Coll London, Dept Med & Mol Genet, Canc Genet Lab, London, England
[5] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
[6] Belfast City Hosp, Dept Haematol, Belfast, Antrim, North Ireland
[7] Oxford Univ Hosp NHS Fdn Trust & Genom, NIHR Oxford Biomed Res Ctr, Oxford, England
[8] Univ Glasgow, Coll Med Vet & Life Sci, Paul OGorman Leukaemia Res Ctr, Sch Canc Sci, Glasgow, Lanark, Scotland
[9] Cardiff Univ, Sch Med, Dept Haematol, Cardiff, Wales
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 200卷 / 02期
关键词：
cytogenetics; flow cytometry; leukaemia diagnosis; molecular genetics; myeloid leukaemia; HEALTH-ORGANIZATION CLASSIFICATION; RESIDUAL DISEASE; RISK;
D O I：
10.1111/bjh.18516
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：150 / 159
页数：10
相关论文
共 50 条
  • [31] Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines tor diagnosis, treatment and follow-up
    Heuser, M.
    Ofran, Y.
    Boissel, N.
    Mauri, S. Brunet
    Craddock, C.
    Janssen, J.
    Wierzbowska, A.
    Buske, C.
    ANNALS OF ONCOLOGY, 2020, 31 (06) : 697 - 712
  • [32] Clostridium difficile laboratory testing in Australia and New Zealand: national survey results and Australasian Society for Infectious Diseases recommendations for best practice
    Ferguson, John K.
    Cheng, Allen C.
    Gilbert, Gwendolyn L.
    Gottlieb, Thomas
    Korman, Tony
    Mcgregor, Alistair
    Richards, Michael
    Roberts, Sally
    Robson, Jenny
    Van Gessel, Helen
    Riley, Thomas V.
    PATHOLOGY, 2011, 43 (05) : 482 - 487
  • [33] Haematology society of Australia & New Zealand myeloma specialists practice network (MSPN) Consensus recommendations on supportive care for patients with multiple myeloma receiving selinexor
    White, Kate
    King, Tracy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S318 - S318
  • [34] Good manufacturing practice protocol based on Wilms' tumour-1 specific cytotoxic T-cells for adoptive immunotherapy in acute myeloid leukaemia
    Buttkereit, U.
    Herrman, E.
    Ottinger, H.
    Beelen, D.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S81 - S81
  • [35] Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukaemia in second remission: a British Society of Bood and Marrow Transplantation Registry study
    Chantry, AD
    Snowden, JA
    Craddock, C
    Marks, DM
    BONE MARROW TRANSPLANTATION, 2006, 37 : S9 - S10
  • [36] The clinical validation and laboratory implementation of fragment analysis for the measurement of the FLT3-ITD allelic ratio in patients with Acute Myeloid Leukaemia
    Wilton, C.
    Newman, B.
    Gudgin, E.
    Scott, M.
    Jones, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 40 - 40
  • [37] The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: Results of the UK MRC AML 10 trial
    Burnett, AK
    Wheatley, K
    Goldstone, AH
    Stevens, RF
    Hann, IM
    Rees, JHK
    Harrison, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (02) : 385 - 400
  • [38] Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: analysis of the UK Medical Research Council AML 10 Trial
    Watson, M
    Buck, G
    Wheatley, K
    Homewood, JR
    Goldstone, AH
    Rees, JKH
    Burnett, AK
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (07) : 971 - 978
  • [39] DIFFERENCES IN MEDICAL COST AND SURVIVAL BETWEEN TRIAL AND NON-TRIAL PATIENTS WITH ACUTE MYELOID LEUKAEMIA - A UK POPULATION-BASED PROPENSITY ANALYSIS
    Wang, H., I
    Aas, E.
    Roman, E.
    Howell, D.
    Painter, D.
    Smith, A.
    VALUE IN HEALTH, 2013, 16 (07) : A394 - A394
  • [40] Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Sill, Heinz
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Zebisch, Armin
    Pichler, Angelika
    Pfeilstoecker, Michael
    Autzinger, Eva-Maria
    Lang, Alois
    Geissler, Klaus
    Voskova, Daniela
    Geissler, Dietmar
    Sperr, Wolfgang R.
    Hojas, Sabine
    Rogulj, Inga M.
    Andel, Johannes
    Greil, Richard
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
12345